BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 11032210)

  • 1. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blair MM; Carson DS; Barrington R
    J Fam Pract; 2000 Sep; 49(9):839-48. PubMed ID: 11032210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
    Hodsman A; Adachi J; Olszynski W
    CMAJ; 1996 Oct; 155(7):945-8. PubMed ID: 8837544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.
    Adachi JD; Roux C; Pitt PI; Cooper C; Moniz C; Dequeker J; Ioannidis G; Cawley MI; Jenkins EA; Walker-Bone KE; Pack S; Stephenson GF; Laan RF; Brown J; Geusens P
    J Rheumatol; 2000 Oct; 27(10):2424-31. PubMed ID: 11036840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucocorticoid-induced osteoporosis].
    Tóth M; Tulassay Z
    Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis.
    Greenspan SL; Harris ST; Bone H; Miller PD; Orwoll ES; Watts NB; Rosen CJ
    Am Fam Physician; 2000 May; 61(9):2731-6. PubMed ID: 10821153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of bisphosphates in treatment of primary and secondary osteoporosis].
    Olszyński WP
    Pol Tyg Lek; 1995 Nov; 50(44-47):56-8. PubMed ID: 8643431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regression.
    Amin S; Lavalley MP; Simms RW; Felson DT
    J Bone Miner Res; 2002 Aug; 17(8):1512-26. PubMed ID: 12162505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.
    Brown JP; Josse RG;
    CMAJ; 2002 Nov; 167(10 Suppl):S1-34. PubMed ID: 12427685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis.
    Homik JE; Cranney A; Shea B; Tugwell P; Wells G; Adachi JD; Suarez-Almazor ME
    J Rheumatol; 1999 May; 26(5):1148-57. PubMed ID: 10332982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates for steroid induced osteoporosis.
    Homik J; Cranney A; Shea B; Tugwell P; Wells G; Adachi R; Suarez-Almazor M
    Cochrane Database Syst Rev; 2000; (2):CD001347. PubMed ID: 10796432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucocorticoid-induced osteoporosis].
    Yasuda S; Kogawa M; Wada S
    Nihon Rinsho; 2003 Feb; 61(2):280-6. PubMed ID: 12638222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid induced osteoporosis.
    Sambrook PN
    J Rheumatol Suppl; 1996 Aug; 45():19-22. PubMed ID: 8856647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.
    Amin S; LaValley MP; Simms RW; Felson DT
    Arthritis Rheum; 1999 Aug; 42(8):1740-51. PubMed ID: 10446876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid osteoporosis: practical implications of recent trials.
    Sambrook PN
    J Bone Miner Res; 2000 Sep; 15(9):1645-9. PubMed ID: 10976984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diphosphonates in the treatment of osteoporosis and in the prevention of associated fractures].
    De Gregorio M; De Gregorio G
    Clin Ter; 1995 Feb; 146(2):123-32. PubMed ID: 7789073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of osteoporosis with bisphosphonates.
    Watts NB
    Rheum Dis Clin North Am; 1994 Aug; 20(3):717-34. PubMed ID: 7984786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoid-induced osteoporosis: recent findings].
    Angeli A; Osella G; Reimondo G; Terzolo M
    Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.